Royce & Associates’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43,399	Closed	-$319K	–	893
2024 Q1	$319K	Sell	43,399 -63,919	-60%	-$469K	﹤0.01%	815
2023 Q4	$401K	Buy	107,318 +76,979	+254%	+$288K	﹤0.01%	804
2023 Q3	$64.3K	Buy	+30,339	New	+$64.3K	﹤0.01%	903